Financials
Income statement
Fiscal date | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
---|---|---|---|---|
Total reported revenue | 4.1T | 3.5T | 4.2T | 3.9T |
Cost of revenue | 3.6T | 3.2T | 4.1T | 3.2T |
Gross profit | 509.7B | 278.1B | 134.8B | 710.3B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 87.8B | 216.8B | 356.7B | 123.7B |
Other operating expenses | 22.4B | 30.3B | 37.7B | 33.9B |
Operating income | 278.4B | -82.6B | -310.5B | 450.5B |
Non operating interest income | ||||
Income | 29.7B | 37.4B | 19.4B | 16.2B |
Expense | 328.1B | 277.1B | 214.8B | 227.6B |
Other income expense | — | — | — | — |
Pretax income | 30.4B | 63.7B | 2.1T | 110.7B |
Tax provision | 22.0B | 26.3B | -73.0B | 79.4B |
Net income | 8.5B | 37.4B | 2.2T | 31.3B |
Basic EPS | — | 0.0 | — | — |
Diluted EPS | — | 0.0 | — | — |
Basic average shares | — | 1.8Qa | — | — |
Diluted average shares | — | 1.8Qa | — | — |
EBITDA | -187.1B | 355.7B | -20.4B | 360.3B |
Net income from continuing op. | — | — | — | — |
Minority interests | -4.6B | -9.3B | -76.1B | -17.1B |
Preferred stock dividends | 0 | 0 | 0 | 0 |